ERBB2 and breast carcinoma: MMTV-erbB2 transgenic mice, a well-established model for mammary tumor risk studies, have been used extensively to study breast cancer risk modulated by hormonal and dietary factors, such as tamoxifen, phytoestrogens, and other estrogen modulators [37,38,39,40].